Articles Tagged With:
-
Talk to each other to improve patient care, reduce readmissions
When hospital staff start examining the reasons patients are being readmitted, the famous line from the movie Cool Hand Luke may come to mind: “What we’ve got here is failure to communicate.”
-
Compliance Mentor - December 2015
-
Aspirin Component Combats Neurodegenerative Disorders
Is a common household drug the key to unlocking the secrets of Alzheimer's disease?
-
Congenital syphilis on rise — What you can do
Are you testing your pregnant patients for syphilis at the first prenatal visit and treating them if infected? If not, it’s time to step up your efforts. An analysis from the CDC shows that after years of decline, the number of congenital syphilis cases reported in the United States increased between 2012 and 2014.
-
Over-the-counter oral contraception is caught up in politics
Over the past several years, a small cadre of socially conservative policymakers and candidates, often hailing from swing states, have started to promote the idea of moving oral contraceptives over the counter as a supposed compromise in the political fight over contraception and, more broadly, reproductive health.
-
Get up to speed on ICD-10 coding for reproductive health services
While the purpose of ICD-10 is to improve clinical communication and accuracy, it will require more precise documentation of clinical care. Clinicians received vital tips on how to integrate the new coding in their family planning practices at the recent Contraceptive Technology Quest for Excellence conference in Atlanta.
-
Pills, patches, and rings — What’s the latest on the second-tier methods?
What are the benefits and disadvantages of such second-tier methods as pills, patches, and rings, and which women can safely use them? These Tier 2 methods, designated by their effectiveness ranking as adapted by the World Health Organization, depend on user behavior such as taking a pill every day or changing the patch or the ring on time.
-
Family planners can look into the future — What contraceptive options are in the pipeline?
What new methods can clinicians look to add to their arsenal of family planning options in the upcoming years? With the recent upsurge in interest in long-acting reversible contraceptives, it’s no surprise that several possible LARC options are moving through the research pipeline.
-
More women reported to be moving to long-acting reversible contraceptives
Results from two analyses of national data indicate that women are increasingly turning to use of long-acting reversible contraceptives such as the intrauterine device and implant for birth control.
-
American Cancer Society’s shift adds confusion on breast screening
The New Year might bring more changes when it comes to breast cancer screening recommendations. A January 2016 consensus conference, called by the American College of Obstetricians and Gynecologists, will bring together major organizations and women’s healthcare providers to evaluate and interpret available data and to develop uniform national guidelines on breast cancer screening.